FDA Approves Symbravo for Acute Treatment of Migraine in Adults
Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severityContinue Reading
Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severityContinue Reading
Approval marks the first and only continuous delivery treatment as an alternate to regular eye injectionsContinue Reading
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson’s disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easingContinue Reading
TUESDAY, Feb. 4, 2025 (HealthDay News) — Many Americans don’t see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks outweigh its benefits, a new survey has found. Nearly half (48%) of people incorrectly think that the benefits of taking low-dose aspirin daily to reduceContinue Reading
TUESDAY, Feb. 4, 2025 (HealthDay News) — Drugs like blood thinners, cholesterol-lowering statins and blood pressure meds can protect the health and extend the lives of people with heart disease. But only if patients take the drugs — and many around the world aren’t, a new study says. Overall, fewerContinue Reading
FRIDAY, Jan. 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin. The new pill, developed by Vertex Pharmaceuticals, is intended for short-term pain relief following surgeryContinue Reading
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of aspirin a day cuts the risk of cancer recurrence in half among colon cancer patients with a mutationContinue Reading
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — COVID-19 continues to be a threat to America’s health, causing more illness and death than either influenza or respiratory syncytial virus (RSV), a new study suggests. COVID accounted for 3 of 5 (60%) respiratory illnesses among military veterans treated by the U.S. VeteransContinue Reading
FRIDAY, Jan. 24, 2025 (HealthDay News) — Hesitancy over the COVID-19 vaccine is leading some parents to skip important vaccinations for their children. Young children of parents who declined the COVID vaccine are about 25% less likely to get the standard measles/mumps/rubella (MMR) vaccine, researchers reported in a new studyContinue Reading
FRIDAY, Jan. 24, 2025 (HealthDay News) — People using weed for medical purposes are as likely – or more – to become addicted to cannabis as recreational tokers, a new study says. Folks using medical marijuana were more likely to have cannabis use disorder than those who get high recreationally,Continue Reading
© 2021 WeeklyMD.com - All Rights Reserved.